par Oumeiri, Bachar El;McEntee, Kathleen
;Annoni, Filippo
;Herpain, Antoine
;Vanden Eynden, Frédéric
;Jespers, Pascale
;Van Nooten, Guido
;Van De Borne, Philippe 
Référence BMC cardiovascular disorders, 18, 1, page (99)
Publication Publié, 2018-05







Référence BMC cardiovascular disorders, 18, 1, page (99)
Publication Publié, 2018-05
Article révisé par les pairs
Résumé : | Aortic regurgitation (AR) is a valvular disease that can lead to systolic heart failure. Treatment options besides cardiac surgery are limited and consequently severe AR is associated with higher mortality and morbidity when not operated. In this investigation, we examined the effects of a novel cardiac myosin activator, Omecamtiv-mecarbil (OM), in rats with chronic severe AR. |